Pertussis disease burden in the household: How to protect young infants

Clinical Infectious Diseases

Volumn 50, Issue 10, 2010, Pages 1339-1345

  De Greeff, S C ^a   Mooi, F R ^a   Westerhof, A ^a   Verbakel, J M M ^b   Peeters, M F ^b   Heuvelman, C J ^a   Notermans, D W ^a   Elvers, L H ^a   Schellekens, J F P ^c   De Melker, H E ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b CPRLab   (Netherlands)

^c Laboratory for Infectious Diseases   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; PERTUSSIS VACCINE;

ARTICLE; BACTERIAL TRANSMISSION; BORDETELLA PERTUSSIS; CHILD; CHILD HEALTH CARE; CLINICAL FEATURE; CONTROLLED STUDY; FATHER; FEMALE; HOUSEHOLD; HUMAN; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MOTHER; NETHERLANDS; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTECTION; SIBLING; VACCINATION;

ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; DNA, BACTERIAL; FAMILY CHARACTERISTICS; FAMILY HEALTH; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NETHERLANDS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; VACCINATION; WHOOPING COUGH;

EID: 77951808897     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/652281     Document Type: Article

References (42)

1. Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007;298:2155-2163.
2. Berbers GA, de Greeff SC, Mooi FR. Improving pertussis vaccination. Hum Vaccin 2009;5:497-503.
3. Mooi FR, van. Loo IH, King AJ. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg Infect Dis 2001; 7:526-528.
4. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005;24:761-765.
5. de Greeff SC, Mooi FR, Schellekens JF, de Melker HE. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J 2008;27:218-223.
6. Mooi F, Van Loo I, Van Gent M., et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 2009; 15:1206-1213.
7. Baron S, Njamkepo E, Grimprel E, et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J 1998; 17:412-418.
8. Deen JL, Mink CA, Cherry JD, et al. Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995;21:1211-1219.
9. Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990; 161:480-486.
10. Wirsing von Konig CH, Postels-Multani S, Bock HL, Schmitt HJ. Pertussis in adults: frequency of transmission after household exposure. Lancet 1995;346:1326-1329.
11. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004;23:985-989.
12. Elliott E, McIntyre P, Ridley G, et al. National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr Infect Dis J 2004;23:246-252.
13. Crowcroft NS, Booy R, Harrison T, et al. Severe and unrecognised: pertussis in UK infants. Arch Dis Child 2003; 88:802-806.
14. Kowalzik F, Barbosa AP, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J 2007;26:238-242.
15. Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007; 26:293-299.
16. Mooi FR, Hallander H, Wirsing von Konig CH, Hoet B, Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis 2000; 19:174-181.
17. Antila M, He Q, de Jong C, et al. Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J Med Microbiol 2006;55:1043-1051.
18. van Doornum GJ, Guldemeester J, Osterhaus AD, Niesters HG. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 2003;41:576-580.
19. Giammanco A, Chiarini A, Maple PA, et al. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 2003;22:112-120.
20. de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000; 38:800-806.
21. van der Zee A, Agterberg C, Peeters M, Mooi F, Schellekens J. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J Infect Dis 1996; 174:89-96.
22. Schellekens J, Boshuizen H, Verbakel J, et al. Serodiagnosis of Pertussis with Commercial. ELISA's. In: Program and abstracts the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2001. Abstract D-1403.
23. Episheet. http://members.aol.com/krothman/modepi.htm. Accessed 29 March 2007.
24. Hellenbrand W, Beier D, Jensen E, et al. The epidemiology of pertussis in Germany: past and present. BMC Infect Dis 2009; 9:22.
25. Mossong J, Hens N, Jit M, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008;5:e74.
26. Statistics Netherlands, http://statline.cbs.nl/statweb/. Accessed 27 September 2009.
27. Bisgard KM, Rhodes P, Connelly BL, et al. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics 2005; 116:e285-e294.
28. de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn-van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 2000; 6:348-357.
29. Grimprel E, Baron S, Levy-Bruhl D, et al. Influence of vaccination coverage on pertussis transmission in France. Lancet 1999;354:1699-1700.
30. Banus S, Stenger RM, Gremmer ER, et al. The role of Toll-like receptor4 in pertussis vaccine-induced immunity. BMC Immunol 2008; 9:21.
31. Wendelboc AM, Hudgens MG, Poole C, Van Rie A. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerg Themes Epidemiol 2007; 4:15.
32. Christie CD, Baltimore RS. Pertussis in neonates. Am J Dis Child 1989; 143:1199-1202.
33. Halperin SA, Wang EE, Law B, et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program-Active (IMPACT). Clin Infect Dis 1999;28:1238-1243.
34. Briand V, Bonmarin I, Levy-Bruhl D. Study of the risk factors for severe childhood pertussis based on hospital surveillance data. Vaccine 2007;25:7224-7232.
35. Juretzko P, von Kries R, Hermann M, Wirsing von Konig CH, Weil. J, Giani G. Effectiveness of acellular pertussis vaccine assessed by hospitalbased active surveillance in Germany. Clin Infect Dis 2002; 35:162-167.
36. Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev 2007:CD004404.
37. Shinall MC Jr, Peters TR, Zhu Y, Chen Q, Poehling KA. Potential impact of acceleration of the pertussis vaccine primary series for infants. Pediatrics 2008; 122:1021-1026.
38. Siegrist CA. Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization. J Pediatr 2008;153:305-307.
39. Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis 2007;7:614-624.
40. Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 2004; 22:3154-3165.
41. Rendi-Wagner P, Paulke-Korinek M, Stanek G, Khanakah G, Kollaritsch H. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria. Pediatr Infect Dis J 2007;26:806-810.
42. de Greeff SC, Lugner AK, van den Heuvel DM, Mooi. FR, de Melker HE. Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies. Vaccine 2009; 27: 1932-1937.